352 results
Page 8 of 18
424B3
7lhad1w43ov
11 Jun 14
Prospectus supplement
12:00am
8-K
EX-99.1
65p l6p4m07cnbfc
2 Jun 14
BioTime to Present at the Jefferies 2014 Global Healthcare Conference
12:00am
8-K
EX-99.1
qxrr09trs8r3ft6xy
30 May 14
Other Events
12:00am
8-K
mdy3xmamf
30 May 14
Other Events
12:00am
8-K
EX-99.1
ood6c
28 May 14
BioTime Receives ISO 13485 Certification for Medical Devices
12:00am
8-K
EX-99.1
p6nnhx
28 May 14
BioTime’s Subsidiary Asterias Biotherapeutics, Inc. Settles Patent Interference Proceedings
12:00am
8-K
EX-99.1
53e4aycphynpv
27 May 14
BioTime’s Subsidiary OncoCyte Corporation and Cornell University Enter License Agreement to Accelerate Lung Cancer Diagnostic Product Development
12:00am
8-K
EX-99.1
c3nkf 8nhb
21 May 14
BioTime, Inc. Subsidiary Acquired Geron Corp’s Therapeutic Stem Cell Assets in Oct. 2013
12:00am
8-K
EX-99.1
lfm34p
7 May 14
LifeMap Solutions, Inc. to Develop Mobile Health Products With Mount Sinai’s Icahn School of Medicine
12:00am
8-K
EX-99.1
jay7aolrwahxgoo
24 Apr 14
BioTime to Present at GTC Stem Cell Summit 2014
12:00am
8-K
EX-99.1
bxy2wmwm7lo1wa4el9u
14 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
lrrar nwc5
8 Apr 14
BioTime to Present at 13th Annual Needham Healthcare Conference
12:00am
424B5
1mqgju8 n4ldfg6
26 Mar 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
n5m5p2egfadflzlf
25 Mar 14
BioTime To Present at Regen Med Investor Day March 26 in New York
12:00am
8-K
EX-99.1
wopf 6coypcpx
18 Mar 14
BioTime Announces Fourth Quarter and Fiscal Year End 2013 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
qkt6 t167d
5 Mar 14
BioTime Raises $3.5 Million Through Preferred Stock Offering
12:00am
8-K
EX-99.1
lrelg
3 Mar 14
BioTime Provides Financing and Product Development Update
12:00am